The role of trefoil factor family in gynecological disease
Authors:
D. Neubert 1; R. Pilka 1; D. Stejskal 2,3; G. Krejčí 3
Authors‘ workplace:
Porodnicko-gynekologická klinika FN a LF UP, Olomouc, přednosta prof. MUDr. R. Pilka, Ph. D.
1; VIA Agel, ředitelka Mgr. Ing. K. Murtingerová
2; Oddělení laboratorní medicíny Středomoravské nemocniční, a. s., přednosta prof. MUDr. D. Stejskal, Ph. D.
3
Published in:
Ceska Gynekol 2016; 81(6): 444-450
Overview
Aim:
Trefoil peptides are a family of small proteins that are expressed in a site-specific fashion by certain epithelial tissues. These peptides appear to be important in mucosal healing processes, in neoplastic disease and in human reproduction.
Design:
Literature review.
Setting:
Department of Obstetrics and Gynaecology, University Hospital, Medical Faculty, Palacký University, Olomouc, Czech Republic; Department of Laboratory Biochemistry, Central Moravian Hospital Trust, Member of Agel holding, Prostějov.
Methods:
Literature review.
Results:
Trefoil peptides are aberrantly expressed by a wide range of human carcinomas and gastrointestinal inflammatory conditions. Outside the gastrointestinal tract, members of this group of peptides have also been identified in the normal hypothalamus and pituitary, and in normal breast tissue where it is responsive to oestrogen stimulation. Evidence of peptide expression has been found in a range of urological, gynaecological, gastrointestinal, pulmonary and breast carcinomas. Furthermore, possible associations between recurrent spontaneous abortion susceptibility and genetic variation in the TFF3 gene were shown.
Conclusion In the future, serum levels of trefoil peptides might be used as markers for neoplastic and inflammatory diseases, as well as some defects of reproduction.
Keywords:
TFF, carcinoma, endometrial, recurrent miscarriage, trefoil factor, serous
Sources
1. Ahmed, AR., Griffiths, AB., Tilby, MT., et al. TFF3 is a normal breast epithelial protein and is associated with differentiated phenotype in early breast cancer but predisposes to invasion and metastasis in advanced disease. Am J Pathol, 2012, 180(3), p. 904–916.
2. Altmae, S., Martinez-Conejero, JA., Salumets, A., et al. Endometrial gene expression analysis at the time of embryo implantation in women with unexplained infertility. Mol Hum Reprod, 2010, 16(3), p. 178–187.
3. Aplin, JD., Hey, NA., Li, TC. MUC1 as a cell surface and secretory component of endometrial epithelium: reduced levels in recurrent miscarriage. Am J Reprod Immunol, 1996, 35(3), p. 261–266.
4. Bignotti, E., Ravaggi, A., Tassi, RA., et al. Trefoil factor 3: a novel serum marker identified by gene expression profiling in high-grade endometrial carcinomas. Br J Cancer, 2008, 99(5), p. 768–773.
5. Bonkhoff, H., Stein, U., Welter, C., et al. Differential expression of the pS2 protein in the human prostate and prostate cancer: association with premalignant changes and neuroendocrine differentiation. Hum Pathol, 1995, 26(8), p. 824–828.
6. Borthwick, JM., Charnock-Jones, DS., Tom, BD., et al. Determination of the transcript profile of human endometrium. Mol Hum Reprod, 2003, 9(1), p. 19–33.
7. Cappelletti, V., Coradini, D., Scanziani, E., et al. Prognostic relevance of pS2 status in association with steroid receptor status and proliferative activity in node-negative breast cancer. Eur J Cancer, 1992, 28A(8–9), p. 1315–1318.
8. Dignass, A., Lynch-Devaney, K., Kindon, H., et al. Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway. J Clin Invest, 1994, 94(1), p. 376–383.
9. Engel, E., Guth, PH., Nishizaki, Y., et al. Barrier function of the gastric mucus gel. Am J Physiol, 1995, 269(6 Pt 1), p. G994–999.
10. Foekens, JA., Portengen, H., Look, MP., et al. Relationship of PS2 with response to tamoxifen therapy in patients with recurrent breast cancer. Br J Cancer, 1994, 70(6), p. 1217–1223.
11. Foekens, JA., Rio, MC., Seguin, P., et al. Prediction of relapse and survival in breast cancer patients by pS2 protein status. Cancer Res, 1990, 50(13), p. 3832–3837.
12. Gipson, IK., Blalock, T., Tisdale, A., et al. MUC16 is lost from the uterodome (pinopode) surface of the receptive human endometrium: in vitro evidence that MUC16 is a barrier to trophoblast adherence. Biol Reprod, 2008, 78(1), p. 134–142.
13. Hanby, AM., Poulsom, R., Elia, G., et al. The expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in ‚gastric metaplasia‘ of the proximal duodenum: implications for the nature of ‚gastric metaplasia‘. J Pathol, 1993, 169(3), p. 355–360.
14. Hanby, AM., Poulsom, R., Singh, S., et al. Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology, 1993, 105(4), p. 1110–1116.
15. Haroun, S., Altmae, S., Karypidis, H., et al. Association between trefoil factor 3 gene variants and idiopathic recurrent spontaneous abortion. Reprod Biomed Online, 2014, 29(6), p. 737–744.
16. Hauser, F., Poulsom, R., Chinery, R., et al. hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. Proc Natl Acad Sci U S A, 1993, 90(15), p. 6961–6965.
17. Henry, JA., Bennett, MK., Piggott, NH., et al. Expression of the pNR-2/pS2 protein in diverse human epithelial tumours. Br J Cancer, 1991, 64(4), p. 677–682.
18. Higashiyama, M., Doi, O., Kodama, K., et al. Estimation of serum level of pS2 protein in patients with lung adenocarcinoma. Anticancer Res, 1996, 16(4B), p. 2351–2355.
19. Hoffmann, W. A new repetitive protein from Xenopus laevis skin highly homologous to pancreatic spasmolytic polypeptide. J Biol Chem, 1988, 263(16), p. 7686–7690.
20. Chinery, R., Cox, HM. Modulation of epidermal growth factor effects on epithelial ion transport by intestinal trefoil factor. Br J Pharmacol, 1995, 115(1), p. 77–80.
21. Jorgensen, KH., Thim, L., Jacobsen, HE. Pancreatic spasmolytic polypeptide (PSP): I. Preparation and initial chemical characterization of a new polypeptide from porcine pancreas. Regul Pept, 1982, 3(3–4), p. 207–219.
22. Kao, LC., Tulac, S., Lobo, S., et al. Global gene profiling in human endometrium during the window of implantation. Endocrinology, 2002, 143(6), p. 2119–2138.
23. Kindon, H., Pothoulakis, C., Thim, L., et al. Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. Gastroenterology, 1995, 109(2), p. 516–523.
24. Lacy, ER., Morris, GP.,Cohen, MM. Rapid repair of the surface epithelium in human gastric mucosa after acute superficial injury. J Clin Gastroenterol, 1993, 17, Suppl. 1, p. S125–S135.
25. Machado, JC., Carneiro, F., Blin, N., et al. Pattern of pS2 protein expression in premalignant and malignant lesions of gastric mucosa. Eur J Cancer Prev, 1996, 5(3), p. 169–179.
26. Machado, JC., Carneiro, F., Ribeiro, P., et al. pS2 protein expression in gastric carcinoma. An immunohistochemical and immunoradiometric study. Eur J Cancer, 1996, 32A(9), p. 1585–1590.
27. Mashimo, H., Wu, DC., Podolsky, DK., et al. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science, 1996, 274(5285), p. 262–265.
28. Masiakowski, P., Breathnach, R., Bloch, J., et al. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res, 1982, 10(24), p. 7895–7903.
29. May, FE., Griffin, SM., Westley, BR. The trefoil factor interacting protein TFIZ1 binds the trefoil protein TFF1 preferentially in normal gastric mucosal cells but the co-expression of these proteins is deregulated in gastric cancer. Int J Biochem Cell Biol, 2009, 41(3), p. 632–640.
30. May, FE., Westley, BR. Cloning of estrogen-regulated messenger RNA sequences from human breast cancer cells. Cancer Res, 1986, 46(12 Pt 1), p. 6034–6040.
31. Mhawech-Fauceglia, P., Yan, L., Liu, S., et al. ER+ /PR+ /TFF3+ /IMP3- immunoprofile distinguishes endometrioid from serous and clear cell carcinomas of the endometrium, p. a study of 401 cases. Histopathology, 2013, 62(7), p. 976–985.
32. Mhawech, P., Benz, A., Cerato, C., et al. Downregulation of 14-3-3sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylation. Mod Pathol, 2005, 18(3), p. 340–348.
33. Piggott, NH., Henry, JA., May, FE., et al. Antipeptide antibodies against the pNR-2 oestrogen-regulated protein of human breast cancer cells and detection of pNR-2 expression in normal tissues by immunohistochemistry. J Pathol, 1991, 163(2), p. 95–104.
34. Playford, RJ., Marchbank, T., Goodlad, RA., et al. Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc Natl Acad Sci U S A, 1996, 93(5), p. 2137–2142.
35. Playford, RJ., Marchbank, T., Chinery, R., et al. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology, 1995, 108(1), p. 108–116.
36. Podolsky, DK., Lynch-Devaney, K., Stow, JL., et al. Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion. J Biol Chem, 1993, 268(9), p. 6694–6702.
37. Poulsom, R., Hanby, AM., Lalani, EN., et al. Intestinal trefoil factor (TFF 3) and pS2 (TFF 1), but not spasmolytic polypeptide (TFF 2) mRNAs are co-expressed in normal, hyperplastic, and neoplastic human breast epithelium. J Pathol, 1997, 183(1), p. 30–38.
38. Probst, JC., Zetzsche, T., Weber, M., et al. Human intestinal trefoil factor is expressed in human hypothalamus and pituitary: evidence for a novel neuropeptide. FASEB J, 1996, 10(13), p. 1518–1523.
39. Rio, MC., Bellocq, JP., Daniel, JY., et al. Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. Science, 1988, 241(4866), p. 705–708.
40. Seib, T., Blin, N., Hilgert, K., et al. The three human trefoil genes TFF1, TFF2, and TFF3 are located within a region of 55 kb on chromosome 21q22.3. Genomics, 1997, 40(1), p. 200–202.
41. Suemori, S., Lynch-Devaney, K., Podolsky, DK. Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family. Proc Natl Acad Sci U S A, 1991, 88(24), p. 11017–1121.
42. Taupin, D., Ooi, K., Yeomans, N., et al. Conserved expression of intestinal trefoil factor in the human colonic adenoma-carcinoma sequence. Lab Invest, 1996, 75(1), p. 25–32.
43. Teklenburg, G., Salker, M., Heijnen, C., et al. The molecular basis of recurrent pregnancy loss: impaired natural embryo selection. Mol Hum Reprod, 2010, 16(12), p. 886–895.
44. Thim, L. A new family of growth factor-like peptides. ‚Trefoil‘ disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins). FEBS Lett, 1989, 250(1), p. 85–90.
45. Tomasetto, C., Rio, MC., Gautier, C., et al. hSP, the domain-duplicated homolog of pS2 protein, is co-expressed with pS2 in stomach but not in breast carcinoma. EMBO J, 1990, 9(2), p. 407–414.
46. Uchino, H., Kataoka, H., Itoh, H., et al. Expression of intestinal trefoil factor mRNA is downregulated during progression of colorectal carcinomas. J Clin Pathol, 1997, 50(11), p. 932–934.
Labels
Paediatric gynaecology Gynaecology and obstetrics Reproduction medicineArticle was published in
Czech Gynaecology
2016 Issue 6
Most read in this issue
- Original Bishop score with modifications
- Breast self-examination. Yes or no?
- Cesarean scar ectopic pregnancy
- Cesarean section incidence and vaginal birth success rate at term pregnancy after myomectomy